Skip to content

Avantor AVTR Common stock, shares issued (in shares)

Common stock, shares issued (in shares) at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
Danaher logo
DanaherDHR
Agilent Technologies logo
Agilent TechnologiesA
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
Element Solutions logo
Element SolutionsESI
DuPont de Nemours, Inc. logo
DuPont de Nemours, Inc.DD

Other financials

Income statement

See full
Revenue$1.6B0.0%
Gross profit$500.7M-6.4%
Operating income$99.5M-32.5%
Net income$43.3M-32.9%
EPS (diluted)$0.06-33.3%

Balance sheet

See full
Cash & equivalents$282.2M-11.4%
Total debt$3.8B-7.1%
Total equity$5.6B-8.4%
Total assets$11.7B-5.4%

Cash flow

See full
Operating cash flow$58.7M-46.3%
CapEx$33.5M+19.6%
Free cash flow$25.2M-69.0%

Valuation

See full
Market cap$6.54B-52.0%
Enterprise value$10.07B-40.4%
P/S-1.0×

Profitability

See full
Gross margin32.1%-1.4pp
Operating margin4%-5.2pp
Net margin-9.2%-19.9pp
FCF margin6.7%-3.3pp

Returns & leverage

See full
Return on equity-10.3%-22.8pp
Debt / equity0.7×0.0×
Current ratio1.8×+0.6×

Where this comes from

Reported directly by Avantor in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.

The official record: Avantor’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Avantor's common stock, shares issued (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Avantor's common stock, shares issued (in shares)?
Avantor (AVTR) reported common stock, shares issued (in shares) of $682.9M in Q1 2026.
How has Avantor's common stock, shares issued (in shares) changed year-over-year?
Avantor's common stock, shares issued (in shares) increased by 0.2% year-over-year, from $681.5M to $682.9M.
What is the long-term trend for Avantor's common stock, shares issued (in shares)?
Over 2 years (2023 to 2025), Avantor's common stock, shares issued (in shares) has grown at a 0.4% compound annual growth rate (CAGR), from $676.6M to $682M.